Quan Zhao

9PUBLICATIONS
22CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsModelling and simulationHaematologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 24, 2026
Noncanonical role of KDM5C in conferring bortezomib resistance via the PERK‒Nrf2 axis in multiple myeloma.

Peifen Lu, Wenbin Shangguan, Weiwei Qian

|Oct 28, 2023
Current Advances and Future Strategies for BCL-2 Inhibitors: Potent Weapons against Cancers.

Jiaxuan Xu, Xiaoqing Dong, David C S Huang

|Aug 12, 2022
Generation of a CRISPR activation mouse that enables modelling of aggressive lymphoma and interrogation of venetoclax resistance.

Yexuan Deng, Sarah T Diepstraten, Margaret A Potts

|Aug 11, 2021
Transcriptional silencing of fetal hemoglobin expression by NonO.

Xinyu Li, Mengxia Chen, Biru Liu

|Jun 27, 2021
TCF3 is epigenetically silenced by EZH2 and DNMT3B and functions as a tumor suppressor in endometrial cancer.

Tao Gui, Ming Liu, Bing Yao

Pageof 2